Skip to main content
. 2022 May 21;29(10):1120–1129. doi: 10.1111/iju.14933

TABLE 3.

Demographic and clinical characteristics, and BCG induction treatment pattern, of the overall patient cohort, complete‐induction cohort, and intensive‐ and non‐intensive‐induction cohorts

Overall (n = 6140) Complete‐induction cohort (n = 4588) Intensive‐induction cohort (n = 2105) Non‐intensive‐induction cohort (n = 2483)
Age, years
Mean (SD) 72.4 (9.6) 72.1 (9.5) 72.1 (9.4) 72.0 (9.6)
Median 73.0 73.0 73.0 73.0
Age categories, n (%)
≤49 years 102 (1.7) 77 (1.7) 33 (1.6) 44 (1.8)
50–59 years 452 (7.4) 358 (7.8) 147 (7.0) 211 (8.5)
60–69 years 1683 (27.4) 1303 (28.4) 625 (29.7) 678 (27.3)
70–79 years 2375 (38.7) 1763 (38.4) 795 (37.8) 968 (39.0)
80–89 years 1439 (23.4) 1031 (22.5) 481(22.9) 550 (22.2)
≥90 years 89 (1.4) 56 (1.2) 24 (1.1) 32 (1.3)
Males, n (%) 5118 (83.4) 3875 (84.5) 1796 (85.3) 2079 (83.7)
BMI, kg/m2 (n = 5154) (n = 4126) (n = 1919) (n = 2207)
Mean (SD) 23.4 (3.4) 23.4 (3.3) 23.5 (3.3) 23.4 (3.3)
Median 23.3 23.3 23.3 23.3
Smoking history, n (%) (n = 4824) (n = 3854) (n = 1759) (n = 2095)
Yes 2343 (48.6) 1893 (49.1) 884 (50.3) 1009 (48.2)
No 2481 (51.4) 1961 (50.9) 875 (49.7) 1086 (51.8)
Cancer stage (version 7), n (%) (n = 3839) (n = 3094) (n = 1431) (n = 1663)
0 1506 (39.2) 1195 (38.6) 553 (38.6) 642 (38.6)
I 2008 (52.3) 1649 (53.3) 759 (53.0) 890 (53.5)
II 208 (5.4) 162 (5.2) 79 (5.5) 83 (5.0)
III 73 (1.9) 53 (1.7) 23 (1.6) 30 (1.8)
IV 44 (1.1) 35 (1.1) 17 (1.2) 18 (1.1)